|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02138 EC HEALTHCARE
Nominal 
0.680 0.000 (0.000%) | 2024/03 - Final HKD(K$) | %Chg (Compare to Final) | 2023/03 HKD(K$) | 2022/03 HKD(K$) | 2021/03 HKD(K$) | 2020/03 HKD(K$) | |
| Turnover | 4,211,034 | 8.661% | 3,875,377 | 2,919,500 | 2,080,403 | 1,948,501 |
| Cost of Sales | -- | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- | -- |
| 2024/03 - Final HKD(K$) | %Chg (Compare to Final) | 2023/03 HKD(K$) | 2022/03 HKD(K$) | 2021/03 HKD(K$) | 2020/03 HKD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | (159) | -95.656% | (3,660) | (297) | (3,344) | (1,737) | |
| Share of Results of Asso. & JCEs | 5,426 | -55.986% | 12,328 | (668) | 4,987 | 121 | |
| Profit / (Loss) before Taxation | 16,874 | -87.610% | 136,189 | 321,411 | 265,896 | 360,523 | |
| Taxation | (1,179) | -95.957% | (29,162) | (50,908) | (40,303) | (50,251) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (34,642) | -7.307% | (37,373) | (73,002) | (32,728) | (23,696) | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (18,947) | -- | 69,654 | 197,501 | 192,865 | 286,576 | |
| 2024/03 - Final HKD(K$) | %Chg (Compare to Final) | 2023/03 HKD(K$) | 2022/03 HKD(K$) | 2021/03 HKD(K$) | 2020/03 HKD(K$) | |
| Net Finance Costs / (Income) | 85,264 | 44.246% | 59,110 | 47,543 | 21,943 | 16,978 |
| Depreciation & Amortisation | 625,545 | 6.615% | 586,735 | 432,365 | 309,863 | 245,783 |
| Directors' Emoluments | 18,786 | -71.024% | 64,833 | 42,708 | 13,286 | 13,604 |
| 2024/03 - Final | %Chg (Compare to Final) | 2023/03 | 2022/03 | 2021/03 | 2020/03 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2024/03 - Final | %Chg (Compare to Final) | 2023/03 | 2022/03 | 2021/03 | 2020/03 | |
| EPS (cts) | -1.600 | -- | 5.900 | 17.100 | 18.800 | 29.100 |
| DPS (cts) | 0.500 | -- | 10.000 | 14.400 | 15.900 | 23.000 |
| Dividend Payout Ratio (%) | -- | -- | 169.492% | 84.211% | 84.574% | 79.038% |
| Cash flow per share ($) | 0.581 | -- | 0.513 | 0.528 | 0.605 | 0.585 |
| NBV per share ($) | 1.655 | -- | 1.565 | 1.596 | 1.185 | 1.018 |
| Remarks: | Real time quote last updated: 30/12/2024 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K$) | HKD 14,097 |
| %Change | 111.953% |
| EPS / (LPS) | HKD 0.012 |
| NBV Per Share ($) | HKD 1.697 |